NCT05583409 2022-10-17SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLCTongji HospitalPhase NA Unknown72 enrolled
NCT04816838 2021-08-25A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR MutationsYonsei UniversityPhase NA Unknown25 enrolled